Press Releases

7/13/2006 Javelin Pharmaceuticals, Inc. Receives Approval for Listing on the American Stock Exchange	5.9 KB
7/7/2006 Javelin Pharmaceuticals Wins Phase II SBIR Grant	6.7 KB
7/6/2006 Javelin Pharmaceuticals CEO to Present at Leerink Swann's Emerging Technologies in Pain Medicine Roundtable and Conference	6.0 KB
6/21/2006 Mark Matthews Joins Javelin Pharmaceuticals as VP of Commercial Affairs	6.9 KB
6/15/2006 Javelin Elects Martin Driscoll and Neil Flanzraich to Board	8.6 KB
5/31/2006 Javelin Enrolls First Patient In Pivotal Phase III Postop Pain Study of Dyloject™	8.5 KB
5/24/2006 Javelin Pharmaceuticals' CEO to Present at Friedman, Billings, Ramsey's 2006 Growth Investor Conference	5.8 KB
5/23/2006 Javelin Enrolls First Patient in Pivotal Phase III Study of Rylomine™	8.1 KB
5/22/2006 Javelin Pharmaceuticals' VP to Give Plenary Lecture at 2nd Annual Specialty Pharma Global Summit	5.9 KB
5/15/2006 Javelin Pharmaceuticals Reports First Quarter 2006 Results	11.4 KB
5/10/2006 Javelin CEO to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference	44.9 KB
5/4/2006 Javelin's Positive Rylomine™ Phase II Clinical Trial Data Presented at the American Pain Society Annual Meeting	11.0 KB
5/1/2006 Javelin Announces Initial Results of a Pilot Phase II Study Of Intranasal Ketamine In Postoperative Orthopedic Pain	8.9 KB
4/24/2006 Stephen Tulipano Joins Javelin Pharmaceuticals as Chief Financial Officer	6.6 KB
4/17/2006 Javelin Pharmaceuticals Files Form 10-K for 2005	6.6 KB
4/12/2006 Leading IP Attorney, David bernstein, Joins Javelin Pharmaceuticals	7.0 KB
4/6/2006 Javelin Pharmaceuticals CEO to Present at BIO 2006 Massachusetts Pavilion	9.5 KB
4/3/2006 Javelin Pharmaceuticals Reports Preliminary Financial Results for 2005 Fiscal Year	8.5 KB
2/23/2006 Javelin presents intranasal morphine safety & efficacy data at the american academy of pain medicine	10.0 KB
2/10/2006 Douglas Hamilton to Step Down as COO/CFO of Javelin Pharmaceuticals, Inc.	5.9 KB
Showing 121-140 of 156 releases Page: 1 2 3 4 5 6 7 8  See Previous 20 | See Next 20

CONTACT US   JOIN US   SITE MAP
© 2010 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.